PROFHILO® STRUCTURA stands out in the regenerative aesthetics market through its unique composition, targeting action, and strong clinical performance.

• Contains 90 mg of ultrapure hyaluronic acid (45 mg high MW + 45 mg low MW) per 2 mL

• Created using patented NAHYCO® thermal technology, with no chemical cross-linking agents

• Injected into superficial fat layers for fat restoration, not just volumization

• 95% of patients reported visible improvements after the first treatment

• Demonstrated +23% increase in tissue thickness at 3 months post-treatment

PROFHILO® STRUCTURA is indicated for the restoration of superficial facial fat in patients experiencing signs of aging, particularly in the midface, cheek hollows, and jawline. It is suitable for individuals with fat loss due to aging or rapid weight loss (e.g., from GLP-1 use like Ozempic®).

Clinical Indications:

• Midface volume loss

• Flattening of facial angles

• Sagging and laxity in the cheek or jaw area

• Restoration of youthful facial proportions

Contraindications:

• Active inflammatory skin conditions or infections at the treatment site

• Hypersensitivity to hyaluronic acid

• Pregnancy or breastfeeding

Reported Side Effects:

• Minimal downtime reported

• Potential for mild redness, swelling, or bruising at injection sites

• Cannula use associated with a 77.1% lower rate of vascular occlusion events

PROFHILO® STRUCTURA is formulated with hybrid cooperative complexes (HCCs) that combine low molecular weight HA (80–100 kDa) and high molecular weight HA (1100–1400 kDa). This formulation ensures deep biocompatibility, tissue integration, and long-lasting activity without requiring chemical stabilizers.

Packaging:

• 1 x 2 mL pre-filled syringe

• 2 TSK cannulas (22G x 50mm & 25G x 38mm)

• 2 pilot needles (21G x 25mm & 23G x 19mm)

• Implant cards and patient leaflet included

Composition:

• Total of 90 mg HA per syringe

• pH-adjusted, ultrapure formulation

• No BDDE or cross-linking agents

• Ideal for bioregenerative applications

PROFHILO® STRUCTURA is administered by qualified professionals into the superficial fat layer, specifically targeting sagging or hollow regions of the midface. The treatment typically follows a two-session protocol, spaced 30 days apart, with minimal discomfort or downtime.

Administration Protocol:

• Injection site: Preauricular region (upper cheek), targeting superficial fat

• Injection technique: Cannula method preferred to reduce vascular risk

• Volume: 2 mL per session (1 syringe)

• Treatment schedule: 2 sessions, 1 month apart

• Post-treatment: No massage needed; patients can resume daily activities

Expected Results:

• +23% increase in tissue thickness observed via clinical imaging

• Improvements in skin firmness, midface projection, and facial angles

• High patient satisfaction (95%) sustained at 3 months post-treatment